Clinical Trial Results

Showing: All studies [change]
Condition: Kidney Disease Location: Michigan 8 trials found
New Search
Filter
Trial Phase
What's the difference?
Study Type
What's the difference?
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
PHASE2INTERVENTIONAL Chicago, Illinois
RECRUITING
Kidney Precision Medicine Project
N/AOBSERVATIONAL Tucson, Arizona +4 more
RECRUITING
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
PHASE3INTERVENTIONAL Washington D.C., District of Columbia +4 more
RECRUITING
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
PHASE1, PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
PHASE4INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
PHASE3INTERVENTIONAL Stanford, California +4 more
RECRUITING
Persona Revision Knee System Outcomes
N/AOBSERVATIONAL Fayetteville, Arkansas +4 more
RECRUITING
Empagliflozin Treatment in Kidney Transplant Recipients
PHASE4INTERVENTIONAL Hines, Illinois +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type